McDermott + Consulting
2019 Life Sciences Dealmaking Symposium
October 
18

Registration

7:30am to 7:45am

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Ticket
$0000
Ticket description
Day Month 0th 0:00pm
Day Month 0th 0:00pm
100 remaining

7:30am to 7:45am

Registration

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Laura McAllister is a host of exceptional ability. Studies show that a vast majority of guests attending events by Laura have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Registration

7:30am to 7:45am

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

7:30am to 7:45am

Registration

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

7:30am to 7:45am

Registration

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Registration

7:30am to 7:45am

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Registration

7:30am to 7:45am

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Mrs Robinson
Wishes you a wonderful day

7:30am to 7:45am

Registration

Alex Zahradnik is a host of exceptional ability. Studies show that a vast majority of guests attending events by Alex have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

McDermott + Consulting
Ticket Sales Are Closed
Text goes here
X
About
Keynote Speaker
Agenda
Sponsors
Event Details
Venture Capital Bootcamp
2019 Life Sciences Dealmaking Symposium

& VENTURE CAPITAL INVESTING BOOTCAMP

THE ROYAL SONESTA BOSTON | CAMBRIDGE, MA
OCTOBER 15-16, 2019

Ticket Sales Are Closed
Text goes here
X

Among the most active markets in private equity, the life sciences sector provides ripe investment opportunities for funds that can navigate the complex regulatory landscape and fast-paced deal environment. At the Life Sciences Dealmaking Symposium and VC Investing Bootcamp, seasoned dealmakers, industry executives and technical experts will join McDermott's leading life sciences and private equity lawyers to help broaden your field of vision as you navigate this dynamic industry.


DAY 1  |  8TH ANNUAL LIFE SCIENCES DEALMAKING SYMPOSIUM

OCTOBER 15, 2019  |  THE ROYAL SONESTA BOSTON  |  CAMBRIDGE, MA 

This “must attend” event for life sciences dealmakers will provide exclusive networking opportunities and in-depth, practical guidance to help you succeed within the vibrant and complex life sciences deal landscape, including:

 

•  Access to 300+ life sciences executives and investors
•  Best practices from seasoned dealmakers, industry executives and technical experts
•  Insight on the critical business, transactional and regulatory issues that impact growth and profitability 

Ticket Sales Are Closed
Text goes here
X

DAY 2  |  LIFE SCIENCES VC INVESTING BOOTCAMP

OCTOBER 16, 2019  |  THE ROYAL SONESTA BOSTON  |  CAMBRIDGE, MA

Exclusively open to venture capital investment professionals, this program is dedicated to the critical IP, regulatory, reimbursement and transaction issues facing VCs making investments in life sciences start-ups. 

 

If you are interested in attending the VC Bootcamp, please submit your information via the button below and a member of our team will contact you shortly.

APPLY TO THE VC INVESTING BOOTCAMP
Text goes here
X
REGISTER
Text goes here
X

keynote speaker

Scott Gottlieb, M.D.

ADD PHOTOS

2019 Life Sciences Dealmaking Symposium

« 1/0 »
START SLIDESHOW PAUSE SLIDESHOW
:credit: :caption:

The 23rd Commissioner of the Food & Drug Administration, Scott Gottlieb, will join McDermott FDA Practice Co-Chair Vernessa Pollard for a lunchtime fireside chat.

Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety.


Life Sciences Dealmaking Symposium Agenda

Note: This is a preliminary list of confirmed speakers. Panels are currently still in formation. Agenda subject to change.

7:30 am – 8:30 am

Networking Breakfast and Registration 

Network with industry peers over breakfast before the conference begins.


8:30 am – 8:45 am

Welcome & Opening Remarks

McDermott's Life Sciences Industry Group Co-Chair Kristian Werling will kick-off the conference.


8:45 am – 9:30 am

M&A Outlook: Transformational Deals in an Evolving Environment

Opportunities abound for dealmakers who can navigate the ever-changing global life sciences deal landscape. However, the transformative transactions in today’s hottest life sciences growth sectors also present new—and sometimes daunting—challenges for your organization. This opening panel will focus on the latest trends in life sciences M&A, and set the stage for the rest of the day’s discussion.


Moderator: Byron Kalogerou, Partner, McDermott Will & Emery


Charlie Attlan, Senior Vice President, Corporate Strategy and Business Development, Boston Scientific

Brittany Bradrick, Vice President, Strategy and Corporate Development, Insulet Corporation

Andrew "Cal" Callaway, Managing Director, U.S. Healthcare Investment Banking, RBC Capital Markets


Peter Lafer, Vice President, General Atlantic

Paris Panayiotopoulos, Managing Director, Blackstone Life Sciences Group

Moderator, Bryan Kalogerou, Partner, McDermott Will & Emery

 

Charlie Attlan, Senior Vice President, Corporate Strategy and Business Development, Boston Scientific

 

Andrew "Cal" Callaway, Managing Director, U.S. Healthcare Investment Banking, RBC Royal Bank

 

Peter Lafer, Vice President, General Atlantic


Paris Panayiotopoulos, Managing Director, Blackstone Life Sciences Group

9:30 am – 10:15 am

Data-Driven Innovation and New Models for Collaboration

As an increasingly vital ingredient in the development of new drugs, devices, and diagnostics, data is creating new opportunities for collaboration.  The proliferation of data creates challenges in structuring these partnerships because of the unique regulatory, privacy and cybersecurity issues involved.  This panel will focus on how partners can create new products using data in this complex and evolving regulatory landscape.

 

Moderator, Jiayan Chen, Partner, McDermott Will & Emery

Eric Bowlin, Partner, Deloitte & Touche LLP


Ed Esplin, Clinical Geneticist, Invitae

 

Debbie Lin, Executive Director, Boehringer-Ingelheim Venture Fund

Sadiqa Mahmood, Senior Vice President of Medical Affairs, Health Catalyst


Emmanuelle Trombe, Partner, McDermott Will & Emery



10:15 am – 10:30 am

Networking Break



10:30 am – 11:15 am

Money Still Doesn’t Grow on Trees: Trends in Early Stage Investment

From gene therapy to digital health and the microbiome, this panel of experienced early-stage investors will discuss where the dollars are going, and the factors that early-stage investors are considering in the current environment as they source and vet new investment opportunities.

Moderator,  Brian Bunn, Partner, McDermott Will & Emery

 

Aftab Kherani, Partner, Aisling Capital

Bruce Robertson, Managing Director, H.I.G. Capital

Akhil Saklecha, MD, MBA, Partner, Cleveland Clinic Ventures

Amarpreet Sawhney, President and Chairman, Instylla

Caitlin Tolman, Vice President, Silicon Valley Bank

Laura McAllister is a host of exceptional ability. Studies show that a vast majority of guests attending events by Laura have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

11:15 am – 12:00 pm

Long Distance Deals: Cross-Border Investment and Collaboration

 It’s an increasingly small world when it comes to collaboration and investment in the life sciences, with cross-border deals redefining the landscape. This panel will discuss trends to look out for in the year ahead, and the role that investment controls such as CFIUS will play in shaping the cross-border marketplace.

Moderator, Sarah Hogan, Partner, McDermott Will & Emery

Anne Altmeyer, Chief Business Officer, Sigilon Therapeutics 


Gabriele Brambilla, CEO, Alira Health

Kleem Chaudhary, Head of Business Development & Licensing, Biogen

Curt Dewan, Business Development Executive, Servier Pharmaceuticals 

Laura McAllister is a host of exceptional ability. Studies show that a vast majority of guests attending events by Laura have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

12:00 pm – 1:30 pm

Networking Luncheon and Keynote Address

A Fireside Chat with 23rd Commissioner of the FDA Scott Gottlieb and McDermott FDA Practice Co-Chair Vernessa Pollard.

Laura McAllister is a host of exceptional ability. Studies show that a vast majority of guests attending events by Laura have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

1:45 pm – 5:00 pm

Breakout Sessions

Afternoon sessions will include an In-House Counsel track and a Business Development & Investor track.

Laura McAllister is a host of exceptional ability. Studies show that a vast majority of guests attending events by Laura have been known to leave more elated than visitors to Santa's Workshop, The Lost of Continent of Atlantis, and the Fountain of Youth.

Track 1  |  In-House Counsel Track (Skyline Suites)

How Artificial Intelligence is Being Deployed in the Life Sciences Industry

1:45 pm – 2:30 pm

From start-ups to global life sciences leaders, life sciences companies are using AI technology in a variety of ways to improve operations.  This panel will explore some of the many use cases, and identify some of the key issues business development teams, investors and in-house counsel need to be aware of.

 

Moderator, Dale Van Demark, Partner, McDermott Will & Emery


Richie Bavasso, Co-Founder, nQ Medical


Stephanie Godfrey, Counsel, Aetna


Susan Harrington, Vice President of Corporate Development, Fresenius Medical Care


Peter Seufer-Wasserthal, Chief Business Development Officer, Origenis GmbH


Post-Merger Integration: The Challenges and Opportunities

2:30 pm – 3:15 pm

Mergers require the synchronizing of corporate structures and corporate cultures, while raising unique regulatory concerns. This panel will discuss how effective pre-merger planning can avoid antitrust concerns, and the potential pain points in managing post-merger integration.

 

Moderator, Jon Dubrow, Partner, McDermott Will & Emery


Clarissa Crain, Senior Manager, Deloitte & Touche LLP

Adam Daly, Vice President, Business Development & Regional General Counsel, Straumann

 

Albert Li, General Counsel, Ottobock

Jeffrey Prowda, Senior Legal Executive (formerly Head of Corporate Counsel at Shire plc) 

 

Karen Valentine,  Chief Legal Officer & General Counsel, Constellation Pharmaceuticals

Track 2  |  Business Development & Investor Track (Grand Ballroom)

Valuation Issues for Investors and Buyers

1:45 pm – 2:30 pm

Whether it be an asset acquisition, a licensing agreement or a full-fledged merger, a lot of factors go into figuring out what an asset is worth. This panel of experts will discuss those factors, and the role that comprehensive due diligence plays in ensuring that you are getting what you pay for.

 

Moderator, Jonathan Ursprung, Partner, McDermott Will & Emery

 

Scott Chamberlin, Senior Vice President and Head of Innovation Banking, Cambridge Trust


Howard Hechler, Vice President of Medtech, Locust Walk

Michael Rachlin, Senior Manager, Deloitte & Touche LLP

 

Lynn Haddad Sommer, Managing Director, Cabrillo Advisors

Private Equity in Life Sciences – Risks and Rewards

2:30 pm – 3:15 pm

Health-focused private equity investors are moving heavily into life sciences and pharma services.  This panel will discuss the risks and opportunities for private equity investors in the life sciences sectors.

 

Moderator, Kristian Werling, Co-Chair, Life Sciences Group, McDermott Will & Emery

David Haigh, Managing Director, Atlantic Global Risk


Jeffrey Schwartz, Managing Director, Bain Capital


Tiffany Yu,  Senior Associate, Equality Asset Management

3:15 pm – 3:30 pm

Networking Break


Track 1  |  In-House Counsel Track (Skyline Suites)

Real World Evidence – The Privacy, Regulatory and Business Considerations for Collection and Use

3:30 pm – 4:15 pm

Life Sciences Innovators are increasingly using real world evidence to understand safety and efficacy, and to support applications for regulatory approval. This panel will focus on privacy, regulatory and business considerations for the collection and use of real world evidence, including the use of apps and wearables.


Moderator, Michael Ryan, Partner, McDermott Will & Emery 


Mujadala "MJ" Abdul-Majid, Legal Director, Regulatory, Ro


Shelby Buettner,
Attorney, Washington DC

Marilyn Hanzal
, Privacy Officer, Flatiron Health


Mika Newton, CEO, xCures, Inc.

IP Angles: How Intellectual Property Considerations Impact Transactions Strategy

4:15 pm – 5:00 pm

IP assets are at the heart of every deal. This panel will focus on how to protect and maximize the value of your IP assets as you go about making deals with others.

Moderator, Nicole Clouse, Partner, McDermott Will & Emery

John Mayfield, Director of Corporate and Business Development, Voyager Therapeutics

Rich Person, Associate General Counsel, Amgen

Aaron Schwartz, Director of R&D Search and Evaluation, Novo Nordisk


Karoline Shair, Head Counsel, IP Program Portfolio, Biogen

Track 2  |  Business Development & Investor Track (Grand Ballroom)

Strategies of the Strategics for External Innovation – CVCs and More

3:30 pm – 4:15 pm

Corporate Venture Capital arms (CVC’s) and Corporate Innovation Centers (CIC’s) are playing an increasingly important role in early-stage investment, and the formation of new partnerships and collaborations.  This panel, featuring representatives from leading CVC’s and CIC’s, will reveal the priorities that these organizations are pursuing, and the impact that they are having on the life sciences marketplace.

 
Moderator, Albert Sokol, Partner, McDermott Will & Emery

Christine Brennan, Ph.D., Partner, MRL Ventures Fund

Vikas Goyal, Senior Vice President of Business Development, Pandion Therapeutics 


Campbell Murray, Managing Director, Novartis Venture Fund

Peter Stebbins, Vice President, Business Development, J&J Innovation

Digital Therapeutics and Cross-Sector Deals: A New Frontier?

4:15 pm – 5:00 pm

With the first digital therapeutics receiving FDA clearance, the future is now in data-driven care management and clinical decision-making. This panel will highlight this emerging space, the unique regulatory issues involved, and the impact of this trend on dealmaking and partnerships.

Moderator, Vernessa Pollard, Partner, McDermott Will & Emery

Uma Makhija, Associate Director of Business Development, Otsuka Pharmaceutical Companies


Kwame Ulmer, Venture Partner, Wavemaker Three-Sixty Health


Joris van Dam, Head of Digital Therapeutics, Novartis


5:00 pm – 6:30 pm

Networking Cocktail Reception


venture capital bootcamp agenda

8:30 am – 9:15 am

Networking Breakfast and Registration


9:15 am– 9:45 am 

Fireside Chat: The Founder and Funder Perspective

Alexandra Manick, Associate Principal, Schooner Capital
Amarpreet Sawhney, President and Chairman, Instylla

9:45 am – 10:30 am

Understanding Investors’ Rights in Series Seed and Series A Transaction Documents – Term Sheets

Brian Bunn, Partner, McDermott Will & Emery
Alexandra Manick, Associate Principal, Schooner Capital
Anthony Paronneau, Partner, McDermott Will & Emery

10:30 am – 10:45 am

Networking Break


 

10:45 am – 11:15 am 

Venture Debt and Other Financing Solutions to Scale for Growth

Caitlin Tolman, Vice President, Silicon Valley Bank
Kate Walsh, Director, Silicon Valley Bank

11:15 am – 12:00 pm

Properly Structuring an Equity Compensation Program

Jonathan Ursprung, Partner, McDermott Will & Emery
Joe Urwitz, Partner, McDermott Will & Emery

12:00 pm – 1:00 pm

Networking Lunch


1:00 pm – 1:45 pm

Risk Mitigation Strategies: Mastering Due Diligence for Life Sciences Investments

Jed Gordon, Partner, McDermott Will & Emery
Sarah Hogan, Partner, McDermott Will & Emery
Paul Radensky, Partner, McDermott WIll & Emery

SPONSORS

PLATINUM SPONSOR

SILVER SPONSOR

BRONZE SPONSOR

EXHIBITOR

STRATEGIC PARTNER

VENTURE CAPITAL BOOTCAMP

VIEW OUR SPONSORSHIP OPPORTUNITIES
Text goes here
X

Event Details

Discover how McDermott + Consulting can help you deliver great services and experiences. The must‑attend event in Philadelphia is the place to learn, connect, and get inspired by visionaries, customers, and partners. This complimentary program offers keynote presentations, educational sessions, access to our partner ecosystem and additional networking opportunities.

 

In the end, it’s all about quality. About an uncompromising commitment to legal excellence, extraordinary client service and a high-performance culture. About helping clients achieve stellar legal and business results—today, and well into the future.

Highlights

  • Participate in workshops to gain hands-on experience in new and innovative digital strategies and tools
  • Enjoy our fourth annual live "game show"-style consultancy competition, live on stage. Watch these young industry hopefuls think on their feet

Venue

40 Edwin H Land Blvd, Cambridge, MA 02142


ACCOMMODATIONS

For your convenience, a limited number of sleeping rooms have been contracted and blocked at the Royal Sonesta Boston. Please book your room reservations online here, or call +617 806 4200.


PARKING
 

There are a few options available at The Royal Sonesta for this event:
Overnight parking: $42.00 rate

Day rates: $24.00 Valet / $22.00 Self-Parking

 

SUGGESTED ATTIRE

Business casual attire is recommended for this program.

WEATHER


Boston's typical weather ranges from 63 during the day to 43 degrees at night in October.

McDermott Will & Emery

Legal Notices / Imprint    Privacy & Cookies Policy    Contact Us

Attorney Advertising   ©2019 McDermott Will & Emery

McDermott
2019 Life Sciences Dealmaking Symposium
RSVPs are closed
Submit
Text goes here
X
Ticket
$0000
Ticket description
Day Month 0th 0:00pm
Day Month 0th 0:00pm
100 remaining
Ticket
$0000
Ticket description
Day Month 0th 0:00pm
Day Month 0th 0:00pm
100 remaining
Tickets closed
Submit
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo
Sorry, ticket sales have closed.